# Polidocanol Injection 2mL (ポリドカスクレロール０．５％注２ｍＬ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3329405A2029). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3329405A2029
- **Product name (Japanese):** ポリドカスクレロール０．５％注２ｍＬ
- **English title:** Polidocanol Injection 2mL
- **Active ingredient:** ポリドカノール
- **Active ingredient (INN):** Polidocanol
- **Strength / unit:** ０．５％２ｍＬ１管
- **Route:** Injection (注射薬)
- **Therapeutic category:** 33 Blood and body fluid agents (血液・体液用薬) › 332 Hemostatics (止血剤)
- **Manufacturer:** Kaigen Pharma (カイゲンファーマ)
- **NHI price (reference only):** JPY 673 per ０．５％２ｍＬ１管
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3329405A2029
- **JSON:** https://www.nifujipharma.com/api/drugs/3329405A2029

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Polidocanol%20Injection%202mL%20(%E3%83%9D%E3%83%AA%E3%83%89%E3%82%AB%E3%82%B9%E3%82%AF%E3%83%AC%E3%83%AD%E3%83%BC%E3%83%AB%EF%BC%90%EF%BC%8E%EF%BC%95%EF%BC%85%E6%B3%A8%EF%BC%92%EF%BD%8D%EF%BC%AC)%20%2F%20YJ%203329405A2029#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Polidocanol

- [Polidocanol Injection 1% (エトキシスクレロール１％注射液)](https://www.nifujipharma.com/drugs/3329405A1022) — １％３０ｍＬ１瓶, Kaigen Pharma
- [Polidocanol Injection 2mL (ポリドカスクレロール１％注２ｍＬ)](https://www.nifujipharma.com/drugs/3329405A3025) — １％２ｍＬ１管, Kaigen Pharma
- [Polidocanol Injection 2mL (ポリドカスクレロール３％注２ｍＬ)](https://www.nifujipharma.com/drugs/3329405A4021) — ３％２ｍＬ１管, Kaigen Pharma